- Home
- HTOOW
as 11-15-2024 4:00pm EST
Fusion Fuel Green PLC is a company that has developed a Green Hydrogen production technology. It is focused on generating cost-effective and competitively priced Green Hydrogen.
| Founded: | N/A | Country: | Ireland |
| Employees: | 116 | City: | N/A |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | N/A |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | N/A | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Fusion Fuel Green PLC Warrant News
HTOOW Breaking Stock News: Dive into HTOOW Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Fusion Fuel Issues Damages Claim Against Hydrogenial S.A. for Failure to Fund $33.5 Million Subscription Agreement; Announces Insolvency of Portuguese Subsidiary
GlobeNewswire
5 days ago
Fusion Fuel Receives Staff Determination Notice from Nasdaq, Submits Appeal Request
GlobeNewswire
3 months ago
Fusion Fuel Green Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
Business Wire
5 months ago
Net Asset Value(s)
PR Newswire
5 months ago
Dstny honored with 'Employee Wellbeing Award'
PR Newswire
5 months ago
Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024
GlobeNewswire
5 months ago
Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval
Business Wire
5 months ago
Entrust Enables Governments to Transform Citizen Interactions with Digital Identities
Compare HTOOW vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HTOOW Fusion Fuel Green PLC Warrant - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.